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Abstract
Tuberculosis (TB) is one of the most devastating infectious diseases worldwide. Whilst global burden estimates for M.
tuberculosis infection (MtTB) are well established, accurate data on the contribution of zoonotic TB (zTB) caused by M. bovis
or M. caprae to human TB are scarce. The association of M. bovis infection with extrapulmonary tuberculosis has been
suggested repeatedly, though there is little scientific evidence available to support this relationship. The present study
aimed to determine globally the occurrence of extrapulmonary TB and the primary site (i.e. primary body location affected)
of zTB in comparison with MtTB, based on previously published reports. A systematic literature review was conducted in 32
different bibliographic databases, selecting reports on zTB written in English, French, German, Spanish or Portuguese. Data
from 27 reports from Africa, America, Europe and the Western Pacific Region were extracted for analyses. Low income
countries, in Africa and South-East Asia, were highly underrepresented in the dataset. The median proportion of
extrapulmonary TB cases was significantly increased among zTB in comparison with data from registries of Europe and USA,
reporting mainly MtTB cases (47% versus 22% in Europe, 73% versus 30% in the USA). These findings were confirmed by
analyses of eight studies reporting on the proportions of extrapulmonary TB in comparable populations of zTB and MtTB
cases (median 63% versus 22%). Also, disparities of primary sites of extrapulmonary TB between zTB and MtTB were
detected. Our findings, based on global data, confirm the widely suggested association between zTB and extrapulmonary
disease. Different disability weights for zTB and MtTB should be considered and we recommend separate burden estimates
for the two diseases.
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Introduction
Tuberculosis (TB) is a disease distributed worldwide, accounting
for an estimated 1.5 million deaths annually [1]. The primary
causative agent of human TB is Mycobacterium tuberculosis.
Tuberculosis in cattle and goats is typically caused by M. bovis
and M. caprae, respectively. Zoonotic transmission of these bacteria
from livestock to humans is well documented [2]. Whilst M.
tuberculosis-related human TB (MtTB) is one of the most
devastating infectious diseases worldwide, the public health
relevance of zoonotic TB (zTB) appears to be minor in
industrialized countries, where milk pasteurization is regularly
performed [3]. However, in developing countries where control
programmes for TB in livestock are absent and milk pasteurization
is not done routinely, zTB may be of considerable importance [4–
6]. A recent systematic literature review estimated incidence rates
of zTB of approximately 7/100’000 human population/year in
Africa [7]. This relatively low incidence rate notwithstanding, the
study revealed that considerable rates of zTB exist in certain high-
risk populations. Moreover, cases of zTB could be considerably
under-diagnosed and consequently under-reported, particularly in
developing countries [4–6].
Disease burden estimates are commonly calculated in terms of
disability-adjusted life years (DALYs), taking into account disease
frequency but also its severity and long-term effects (sequelae) [8].
The disability weights of zTB caused by M. bovis and M. caprae may
differ from those of MtTB. A main reason may be associated with
the different primary sites (i.e. primary body location affected) of
disease for zTB and MtTB and potentially distinct secondary
consequences resulting from this. An association of M. bovis
infection with extrapulmonary TB has been suggested repeatedly
in the literature, and current dogma suggests zTB to be
transmitted to humans primarily by ingestion of contaminated
products of animal origin rather than by aerosols, a hypothesis that
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would be in line with the more frequent extrapulmonary
presentation of zTB in humans [3,6,9]. This view is mainly based
on analysis of historical data from high-income countries and few
other studies in geographically restricted regions or including small
study populations. More comprehensive analyses investigating on
a global scale the relative proportion of pulmonary versus
extrapulmonary TB cases in humans and the primary sites of
disease for zTB infection are missing. Other factors potentially
affecting the clinical picture of zTB appear to be age, sex and co-
morbidities (especially co-infection with the Human Immunode-
ficiency Virus; HIV). For example, an early study conducted in the
UK revealed that TB caused by M. bovis in children was nearly
always extrapulmonary [10]. Males may have a higher risk of
infection with zTB due to their more frequent intensive contact to
cattle, either at farms or in abattoirs [11].
The present study was mandated by the World Health
Organization (WHO) Foodborne Disease Burden Epidemiology
Reference Group. It aimed, based on available scientific
evidence, to determine the proportion of extrapulmonary TB
and the primary site of zTB and its association with patient
demographic parameters and HIV co-infection status. It
combines for the first time observational and intervention
studies on this topic from all geographical regions and without
restriction to specific study populations and used systematically
selected high-quality data to explore the association between
zTB and extrapulmonary TB.
Methods
Systematic selection of eligible reports and data
extraction
A systematic multi-lingual literature search was performed
according to Cochrane guidelines with certain modifications
(http://cochrane-handbook.org/). Thirty-two different biblio-
graphic databases were searched for potentially relevant reports
on putative zTB cases (M. bovis or M. caprae infections) in humans
published until March 2010 using a highly sensitive search syntax
(Tables S1 and S2). We included all types of observational and
interventional studies on zTB or M. bovis and M. caprae infections
in humans, unless the study reported exclusively on cases with
evident human-human transmission. Before and after removal of
duplicated reports 18’485 and 12’176 records, respectively, were
identified (Figure 1). Titles and abstracts were screened to exclude
reports which were unlikely to contain information on zTB cases;
1’203 potentially relevant reports remained of which 447 (37%)
were available online and assessed for eligibility. We focused on
reports available online for convenience while this was an
important factor to improve the efficiency of the work. Moreover,
it can be assumed that reports available online are of higher
quality and that most of the more recent reports were available.
Eligible records were written either in English, French, German,
Spanish or Portuguese. Additionally, studies had to report on
either the occurrence of extrapulmonary TB, primary site or
sequelae of the disease. They had to include at least 10 individuals
with zTB. No restrictions were made on the year when the study
was undertaken. Eligibility of the relevant reports was assessed
independently by three operators on 100 randomly selected
reports. Ambiguities and diverging judgements were examined in
order to harmonize the selection procedure. The remaining
records were randomly assigned to one operator only. Thirty-
seven reports were considered eligible for data extraction. Data
was extracted stratified by WHO region, sex, age group and HIV
co-infection of the patients, where possible. Data were sought for
20 variables (Table S3). After harmonizing the procedure of data
extraction done by three operators based on 15 reports, the
remaining reports were randomly allocated to one operator only.
If any of the included reports were referring to relevant accessible
external data which were not included in the database during
earlier steps, these data were included as well in the analysis. Data
on more than one study setting (different geographical regions and
study periods) were available from two reports which enlarged the
database by five records. A total of 15 reports had to be excluded
for different reasons (Figure 1). The final database included 27
records from 26 different reports. Within these reports, differen-
tiation of M. bovis, M.caprae and M. tuberculosis was done by
molecular (e.g. PCR, spoligotyping), biochemical or both methods,
or was not further specified for six reports. Anonymized human
medical data was used.
Source of M. tuberculosis data
Human TB registries from the USA and Europe were screened
for information on the proportions of extrapulmonary TB cases
and the primary sites of the disease. The reports did not distinguish
between different species of the M. tuberculosis complex and
consequently included M. bovis cases. Data from registries of the
USA for the years 2005 to 2010 was used (Reported Tuberculosis
in the United States, Department of Health and Human Services,
[12]). For Europe, data were sourced from the EuroTB reports
(InVS/KNCV, funded by the European Commission, [13]) and
from the Tuberculosis surveillance in Europe reports (ECDC and
WHO, [14]) for the years 1998 to 2006 and 2007 to 2010,
respectively. The former included data from the European
Economic Area (EEA) states, Israel and Switzerland; the latter
included data of the EEA states only.
Categorization of TB sites and analysis of the data
The primary sites of TB infection were categorized according to
the ICD10 (International Statistical Classification of Diseases and
Related Health Problems 10th Revision) online tool (http://apps.
who.int/classifications/apps/icd/icd10online/). As an exception,
we classified TB of the pleura as extrapulmonary, in agreement
with most reports and registries that classify pleural TB as
extrapulmonary TB, unless co-existing in a patient with pulmo-
nary TB. Affected lymph nodes (also including non-defined lymph
nodes) were counted as extrapulmonary TB whereas affected
Author Summary
Tuberculosis (TB) is one of the most devastating infectious
diseases worldwide. The impact estimation of worldwide
human TB is well established; however, that of TB
transmitted by cattle, goat or sheep (i.e. zoonotic TB) is
not. The affected body sites of human and zoonotic TB are
repeatedly suggested to be different, which would
influence the severity and impact of the diseases. The
present study aimed to determine globally the association
of affected body site and zoonotic TB by a systematic
literature review. Data from 27 reports from Africa,
America, Europe and the Western Pacific Region were
included in the analyses. We found that the proportion of
extrapulmonary TB was significantly higher in zoonotic TB
than in human TB. Also, disparities of the specific body
sites of extrapulmonary TB between zoonotic TB and
human TB were detected. Our findings, which are based
on global data, confirm the widely suggested association
between zoonotic TB and extrapulmonary disease. There-
fore, different measurements for estimating the impact of
the two diseases should be considered.
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Figure 1. Selection procedure with inclusion and exclusion criteria for the 27 reports included in the study and their uses in analysis.
doi:10.1371/journal.pntd.0002399.g001
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mediastinal lymph nodes were classified as pulmonary TB.
Tuberculosis of the nervous system included meningeal TB, TB
of the brain and spinal cord and of undefined nervous tissue.
Tuberculosis of the intestines, peritoneum and mesenteric glands
were categorized as intestinal TB. Patients with both pulmonary
and extrapulmonary TB were defined as extrapulmonary cases
throughout the study for both zTB and MtTB.
We compared the frequency of extrapulmonary disease and
of primary sites of zTB with MtTB in two ways. First, zTB cases
from the selected reports were compared with cases reported in
TB registries (mainly M. tuberculosis), using the one sample
Wilcoxon signed rank test. Second, information on comparable
populations of M. bovis and M. tuberculosis cases within the same
study were reported in eight reports regarding the occurrence of
extrapulmonary TB and in four reports regarding the primary
sites of TB infection (Table S4, footnote 3 and 4). The
Wilcoxon matched pairs signed rank test was used for
comparing the reported proportions. No weighting by study
size was applied.
The bibliography database was stored in Reference Manager
v11.0.1 bibliographic software. The data extracted was collated
and stored in an access file. Data analysis was done using the
statistical software R version 2.13.1 (http://cran.r-project.org/).
Results
Availability of data
Twenty-seven reports from four different WHO regions (Africa,
1 report; America, 8; Europe, 15; Western Pacific region, 3) were
included in the present study (Tables S4 and S5, Figure 2). The
single study from Africa was done in Madagascar [15]. Half of the
reports from Europe were carried out in the UK and Ireland. Six
reports originated from the USA, 50% of which reported data
from San Diego County, California, an area with a high
proportion of Hispanic residents [16–18]. Reports included data
from 1927–2007 whereas only 7 reports included data from earlier
than 1980 (Table S4). Two studies from Europe reported on TB
caused by M. caprae [19,20] while the remaining of the zTB cases
reported was caused by M. bovis. Sample sizes of zTB patients
ranged from 10–296 cases with a median of 69 cases.
Occurrence of extrapulmonary zTB and comparison to
MtTB
Information on the proportion of extrapulmonary TB cases
among all zTB patients was presented in 26 of the studies included
(Table S4, footnote 1) and varied substantially between and within
WHO region (Table 1, Figure 3). The region with the highest
median value of extrapulmonary TB cases (73%, range 46–95%)
was the Americas. Two studies from USA, which reported high
proportions of extrapulmonary TB (95% and 74%, respectively),
were conducted in specific populations. The first report included
children only (0–15 years) [18] and the second was related to a
food-borne outbreak caused by unpasteurized cheese, where a
high proportions of extrapulmonary TB is expected [21].
Nevertheless, two other studies conducted in representative
populations from the State of Michigan and the whole of the
USA covering a period of 10 years, also reported proportions of
73% and 74% [22,23]. According to the estimates in the studies
conducted in Europe, the median proportion of extrapulmonary
TB was 47% (21–99%). The only report from Africa presented a
low proportion of extrapulmonary TB (11%) [15]. The three
studies included from the Western Pacific region reported
proportions of extrapulmonary TB from 13–43% with a median
of 28% [11,24,25].
The proportion of extrapulmonary zTB based on our dataset
was significantly higher than within TB cases (mostly consisting of
MtTB) reported in TB registries. For Europe, the median
proportion of extrapulmonary TB among cases of zTB was more
than two-fold of that of MtTB (47% for zTB vs. 22% for MtTB,
n= 15, V= 119, p,0.001). For the USA, this difference was even
more pronounced (73% for zTB vs. 30% for MtTB, n= 6, V= 21,
p = 0.031).
These findings were confirmed by analyses of the proportions of
extrapulmonary TB within the eight studies reporting on
comparable populations of both, zTB cases and MtTB cases
(Table S4, footnote 3). The proportion of extrapulmonary TB was
significantly higher among zTB cases than among MtTB cases
(median 63% vs. 22%, n= 16, V= 36, p= 0.008; Figure 4). Four
of these reports originated from the USA [16–18,22] with three
from the San Diego County, California, two from England [26,27]
and one each from Ireland [28] and New Zealand [25].
Figure 2. World map with the origin of data included in this study.
doi:10.1371/journal.pntd.0002399.g002
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Only one eligible study reported data stratified by sex and found
a more than two-fold increased proportion of extrapulmonary
cases in women (21/43 patients, i.e. 49%) than in men (20/103
patients, i.e. 19%) [11].
Primary sites of extrapulmonary zTB and comparison to
MtTB cases
The primary sites of extrapulmonary zTB were reported
and analysed in 19 reports (Table S4, footnote 2). Overall,
lymph nodes (median of the proportions of affected lymph
nodes among all extrapulmonary cases within each
study = 30%) and the genitourinary system (median = 25%)
were most often affected, followed by bones and joints
(median = 13%), intestines and peritoneum (median = 6%)
and the nervous system (median = 5%) (Table 2). This
frequency distribution did not differ greatly between studies
from Europe and the Americas with the exception of
genitourinary TB having been detected in only two of five
studies conducted in the Americas [29,30] whereas in 8 of 10
studies conducted in Europe.
Comparing the primary sites of extrapulmonary zTB of our
dataset with the data from European TB registries reporting
mainly MtTB cases, extrapulmonary zTB was negatively associ-
ated with infections of the pleura (median = 0% vs. 27% in MtTB,
n= 10, V= 1, p = 0.004) and by trend with miliary TB
(median= 0% vs. 6% in MtTB, n= 10, V=10, p = 0.07) but
positively associated by trend with infections of the genitourinary
system (median= 25% vs. 10% in MtTB, n= 10, V= 46, p= 0.07)
and bones and joints (median = 17% vs. 8% in MtTB, n= 10,
V= 46, p = 0.07). For the USA, no different lesion location was
detected when comparing data from TB registries with those from
zTB reports.
Information on the primary sites of extrapulmonary TB cases
within comparable populations of zTB and MtTB cases were
reported in two reports from the USA [18,22], and one each from
Mexico [29] and England [26] of our dataset (Table S4, footnote
Table 1. Absolute numbers and proportions of pulmonary and extrapulmonary TB.
Report ID Total number of patients Pulmonary TB extrapulmonary TB
a
Unknown location
n % n % n
Africa
140 18 16 89 2 11 0
America
485a 31 13 42 18 58 0
317 61 3 5 58 95 0
164 167 80 48 87 52 0
51 13 3 27 8 73 2
46 165 43 26 122 74 0
155 35 9 26 26 74 0
48 132 71 54 61 46 0
Europe
598 264 2 1 262 99 0
338 38 17 53 15 47 6
485b 94 54 57 40 43 0
485c 102 65 64 37 36 0
612 77 16 21 61 79 0
588 201 82 41 119 59 0
149 13 10 77 3 23 0
425 30 16 53 14 47 0
515 10 5 50 5 50 0
521 228 78 38 125 62 25
162 19 15 79 4 21 0
74 296 113 49 119 51 64
219 166 85 60 57 40 24
87 11 3 30 7 70 1
13 110 69 68 33 32 8
Western Pacific
337 148 106 72 42 28 0
134 34 17 57 13 43 4
55 15 13 87 2 13 0
The number of unknown location is presented for completeness and was subtracted from the total number of patients before calculating the proportions.
aincludes some patients with both pulmonary and extrapulmonary TB.
doi:10.1371/journal.pntd.0002399.t001
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4). Lymph nodes (in all four reports), the genitourinary tract, the
intestine tract and the skin tended to a positive association for
extrapulmonary zTB (Figure S1). In contrast, bones and joints, the
nervous system and the pleura were more often affected by trend
in extrapulmonary MtTB cases. No significant difference in
primary sites between zTB and MtTB was found using the
Wilcoxon matched pairs signed rank test.
Discussion
Global data on zTB infection and its relation to extrapulmonary
TB are scarce. Studies investigating these aspects are needed in
order to accurately estimate the global burden of this disease and
to explore how it differs from the burden of MtTB. Moreover, until
now, the assumption of zTB being associated with extrapulmonary
TB, has been based mostly on historical data from high-income
countries and on few individual studies from geographically
restricted regions or including small study populations. The
present study analysed the frequency distribution of extrapulmo-
nary zTB based on previously published reports. By combining the
results from multiple reports without restriction to geographical
regions or population groups, it aimed to explore the best possible
evidence of the association between zTB and extrapulmonary TB.
Additionally, the findings were compared to MtTB using registries
on human TB infections and comparing comparable populations
of M. bovis and M. tuberculosis infected patients within the same
Figure 3. Proportion of extrapulmonary sites of TB per WHO region (n= the number of studies per region). The circle diameter is
proportional to the number of patients included in the study. The diamond represents the median proportion of the respective region. *significant
differences exists only between the WHO regions America and Western Pacific (two sample Wilcoxon signed rank test, n = 10, W=21, p = 0.017).
doi:10.1371/journal.pntd.0002399.g003
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studies. To our knowledge, this is the first study globally
investigating the association between zTB and extrapulmonary
TB as well as the primary sites of infection of extrapulmonary
zTB.
Our study showed an increased proportion of extrapulmonary
TB among zTB compared to MtTB. While the comparison
between zTB of the individual records and MtTB of the registries
may be questionable because of diverse study settings, the
comparison between zTB and MtTB within the same study is
more robust and revealed an association of zTB and extrapulmo-
nary TB as well. Similar results were reported previously, but
mostly performed in geographically restricted regions (e.g. [9,31]).
The reason for this association may be explained by the different
transmission routes, as zoonotic infection is primarily caused by
consumption of unpasteurized dairy products. However, since the
introduction of milk pasteurization in the 1950/60s in Europe and
Northern America, patients with M. bovis infection in these regions
suffered more often from reactivation of old infections, which
mainly leads to pulmonary TB [3,11,30,32]. This supports the
decreasing trend of association of zoonotic and extrapulmonary
TB over time that we observed in our analysis (Figure S2).
The occurrence of extrapulmonary zTB was very heteroge-
neous. This heterogeneity was found within and across different
WHO regions and countries, likely due to different populations at
Figure 4. Proportion of extrapulmonary site of TB of the eight studies which reported on both, cases caused by M. bovis and M.
tuberculosis (gray lines combine data from the same studies). The circle diameter is proportional to the number of patients included in the
study.
doi:10.1371/journal.pntd.0002399.g004
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risk in the different areas. However, there may be other factors
underlying the different affected organs for zTB. The data
extracted from our review does not allow a detailed investigation
of these potential factors.
While we did not perform a formal risk of bias analysis, data
were extracted from the reports to explore possible factors
influencing our findings (Table S5). For example, the study
population never corresponded to a representative population of a
region. When the sampling strategy and the case finding strategy
were reported, it was mostly and always, respectively, done by
convenience and passively, whose effectiveness might differ
between geographical regions and individual studies. Also,
differentiation methods of M. bovis from M. tuberculosis were not
homogenous between the different studies. However, we did not
find a significant difference between the proportion of extrapul-
monary TB in various reports which used molecular and
biochemical identification methods (Wilkoxon rank sum test,
n = 21, W=64, p = 0.238). Furthermore, our analyses were
influenced by the technical constraints of the studies included.
For example, the paucibacillary nature of extrapulmonary TB
complicates culture and speciation of bacteria, in particular, in
low-income areas with limited laboratory infrastructure and still
common use of the classical Lo¨wenstein-Jensen medium which is
less sensitive than the newer BACTEC systems. However, since
this may affect all ecotypes of the M. tuberculosis complex, it is
unlikely to affect our conclusions regarding the frequency and
distinct primary sites of extrapulmonary infection for M. bovis and
M. tuberculosis.
The proportion of extrapulmonary TB for zTB and MtTB may
be overestimated by the categorization of patients with both
pulmonary and extrapulmonary TB as extrapulmonary cases. This
categorization would be incorrect in cases where extrapulmonary
disease is an advanced clinical picture of a primary pulmonary
infection. However, as this categorization was applied for zTB and
MtTB, the conclusion for the comparison of the two agents may
not be affected.
Comparison of the occurrence of primary extrapulmonary sites
between zTB and MtTB also revealed differences. This observa-
tion was made for studies conducted in Europe but not in the
USA, which may be caused by different transmission routes in the
two geographical regions. Further investigation would be needed
to assess the transmission ways for different regions and
populations at risk.
For Europe and North America, available data cover large
regions over a period of more than 50 years (1954–2007) providing
a good overview of the situation in these regions. Low income
countries, as Africa and South-East Asia, were highly underrep-
resented in the dataset. As milk pasteurization in most of these
countries is not yet routinely done [6], it is very likely that the
consumption of dairy products is the main transmission route of
zoonotic TB and therefore it is expected that the differences
between the occurrence of extrapulmonary TB owing to zTB and
MtTB are more pronounced than in Europe and America.
However, the almost complete lack of information from these
areas makes it almost impossible to draw conclusion which are also
valid for Africa and Asia. Additionally, our findings might be
subject to publication bias because small studies without spectac-
ular findings are less likely to get published.
Data on demographic parameters was rarely reported in the
publications included in the review. Only one study, reporting on
TB sites stratified by sex, had a sufficiently high sample size to
draw any conclusion [11]. Also, data stratified by age category
were limited with unevenly reported age classes and contradictory
report results. Three studies reported higher proportions of
extrapulmonary TB in young children [21,33,34]. Two of them
were surveys which retrospectively analysed M. bovis infections of
10 and 11 hospitalized patients, respectively, over a period of 5
years from 1986–1990 in Spain and 6 years from 2000–2005 in
France, respectively [33,34]. It was hypothesized in both reports
that the higher proportion of pulmonary TB was a result from
reactivated older infection caused by dairy products, which had
not been routinely pasteurized when these patients were born.
Three patients from France, all aged between 35 and 40 years
including two with extrapulmonary TB, were born in Africa where
the risk of infection by unpasteurized milk products, and therefore
extrapulmonary disease, is higher [33]. The third report was on a
foodborne outbreak associated with unpasteurized cheese in New
York City, where all of the five children below five years of age
suffered from extrapulmonary TB while 9 of the 30 patients aged
from 5–76 years showed pulmonary TB [21]. One study, a survey
from 1995 in France, reported higher proportions of extrapulmo-
nary TB in adults [35]. However, only two patients, both with
pulmonary TB, were younger than 15 years. Interestingly, both of
them were born in Africa from where extrapulmonary TB would
be expected to be more likely. Finally one larger study including
patients from 1986–1990 in England and Wales reported similar
proportions of pulmonary and extrapulmonary TB for patients
above and below 30 years of age [36]. Only two reports were
available which reported on deaths among extrapulmonary and
pulmonary zTB and they revealed contradictory results [16,37].
To draw conclusions on the fatal outcome of extrapulmonary
versus pulmonary zTB is therefore impossible. Only one report
from Mexico included information on primary sites of extrapul-
monary zTB stratified by the HIV co-infection of the patients [29]
and it was therefore not possible to analyse the influence of HIV/
AIDS on the TB sites.
For a proper DALY calculation, demographic and mortality
data on the respective disease are required. The limitations of the
availability of these data in our dataset impede therefore DALY
calculations for zTB. However, the significant differences in the
occurrence of extrapulmonary TB and primary sites of the disease
between zTB and MtTB detected in the present study demonstrate
evidence for different disease sequelae. We may conclude that,
regarding the differences in disease sequelae for the two causative
agents, separate parameters for the DALY calculation should be
used for zTB.
Our findings, based on previously published global data,
corroborated the widely stated, albeit rarely demonstrated
association between TB caused by M. bovis or M. caprae and
extrapulmonary disease. Disparities between zTB and MtTB were
also suspected for specific sites of extrapulmonary TB. We do not
know how well this conclusion fits the African and Asian situation,
owing the almost complete lack of data. Therefore, investigations
in these regions, where zoonotic TB is still relevant, are urgently
required to assess the global universality of the conclusions.
Nevertheless, there is evidence that the degree of disability weights
for zTB and MtTB differ and therefore, to measure most
accurately the socio-economic impact of TB, burden estimation
should be conducted separately for zTB and MtTB.
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